Business Description
Vanda Pharmaceuticals is a Washington, D.C.-based company that develops and sells medicines for conditions that are difficult to treat, including schizophrenia, bipolar disorder, sleep disorders, multiple sclerosis, and motion sickness. Its current lineup of approved treatments includes Fanapt, HETLIOZ, PONVORY, and NEREUS, while its research pipeline covers a broad range of additional conditions such as depression, psoriasis, cancer, cystic fibrosis, and anxiety disorders. Founded in 2002, the company continues to expand both its commercial offerings and its portfolio of treatments under development.
